Why ResMed (RMD) is Poised to Beat Earnings Estimates Again

Core Insights - ResMed is positioned to continue its earnings-beat streak, having a history of exceeding earnings estimates, particularly in the last two quarters with an average surprise of 7.40% [1][2] Earnings Performance - For the most recent quarter, ResMed reported earnings of $2.13 per share, surpassing the expected$1.92 per share by 10.94%. In the previous quarter, it reported $1.88 per share against an expectation of$1.81 per share, resulting in a surprise of 3.87% [2] Earnings Estimates and Predictions - Recent estimates for ResMed have been increasing, with a positive Earnings ESP of +2.85%, indicating bullish sentiment among analysts regarding the company's earnings prospects. This is combined with a Zacks Rank of 3 (Hold), suggesting a potential for another earnings beat [3][6] Statistical Insights - Stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise, indicating a strong correlation between these metrics and earnings performance [4][5]